Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.79 |
| ▸ | MAPT | P10636 | 6/20 | 0.79 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.79 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.79 |
| ▸ | RAB9A | P51151 | 4/20 | 0.73 |
| ▸ | LMNA | P02545 | 6/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | NPC1 | O15118 | 3/20 | 0.64 |
| ▸ | NCF1 | P14598 | 3/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6031547 | 1.00 | KDM4E (0.79) | KDM4EMAPTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL15533104 | 0.92 | MAPT (0.69) | KDM4EMAPTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL27858514 | 0.92 | KDM4E (0.69) | KDM4EMAPTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL18844291 | 0.92 | MAPT (0.69) | KDM4EMAPTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5170654 | 0.92 | MAPT (0.69) | KDM4EMAPTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL18816619 | 0.92 | MAPT (0.69) | KDM4EMAPTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL18816623 | 0.92 | MAPT (0.69) | KDM4EMAPTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL4947880 | 0.92 | KDM4E (0.69) | KDM4EMAPTCYP1A2CYP3A4CYP2C9 | |
| Hydrochloric Acid SCHEMBL9438985 | 0.91 | MAPT (0.68) | KDM4EMAPTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL8059724 | 0.91 | MAPT (0.68) | KDM4EMAPTCYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612391-B2 | Cromolyn derivatives and uses thereof | THE GENERAL HOSPITAL CORPORATION (US) | 2026-04-28 | — | — | US | disclosed |
| US-12583881-B2 | Device and cassette for performing a plurality of synthesis processes of preparing a radiopharmaceutical in series | OUT AND OUT CHEMISTRY S.P.R.L. (BE) | 2026-03-24 | — | — | US | disclosed |
| US-20260014284-A1 | PROCESS FOR PREPARATION OF RADIOLABELED STYRYLPYRIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF | JUBILANT DRAXIMAGE INC (CA) | 2026-01-15 | — | — | US | disclosed |
| US-12383528-B2 | Cromolyn esters and uses thereof | THE GENERAL HOSPITAL CORPORATION (US) | 2025-08-12 | — | — | US | disclosed |
| WO-2025122011-A9 | TRIGLYCERIDE ANALOGS | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) | 2025-07-17 | — | — | WO | disclosed |
| WO-2025122011-A1 | TRIGLYCERIDE ANALOGS | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) | 2025-06-12 | — | — | WO | disclosed |
| US-20250025581-A1 | Medical Imaging of Glycogen Synthase Kinase-3 with a PET Probe | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2025-01-23 | — | — | US | disclosed |
| US-20240327361-A1 | RADIOLABELED COMPOSITIONS AND METHODS OF USE THEREOF | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2024-10-03 | — | — | US | disclosed |
| EP-4433454-A2 | MEDICAL IMAGING OF GLYCOGEN SYNTHASE KINASE-3 WITH A PET PROBE | Mayo Foundation for Medical Education and Research (US) | 2024-09-25 | — | — | EP | disclosed |
| US-12090157-B2 | Non-invasive pet imaging of CDK4/6 activation in cancer | NEW YORK UNIVERSITY | 2024-09-17 | — | — | US | disclosed |
| WO-2023205291-A2 | TARGETING MYOCARDIAL TISSUE FOR DELIVERY OF THERAPEUTIC AND IMAGING AGENTS | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2023-10-26 | — | — | WO | disclosed |
| WO-2023163033-A1 | NOVEL COMPOUND, α-SYNUCLEIN AGGREGATE BINDER, AND USE THEREOF | 国立研究開発法人量子科学技術研究開発機構 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023091697-A2 | MEDICAL IMAGING OF GLYCOGEN SYNTHASE KINASE-3 WITH A PET PROBE | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2023-05-25 | — | — | WO | disclosed |
| CN-115109120-A | CD 8-specific capture agents, compositions and methods of use and preparation | 英蒂分子公司 | 2022-09-27 | — | — | CN | disclosed |
| WO-2022174193-A1 | RADIOLABELED COMPOSITIONS AND METHODS OF USE THEREOF | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2022-08-18 | — | — | WO | disclosed |
| WO-2022146914-A1 | CROMOLYN DERIVATIVES AND USES THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2022-07-07 | — | — | WO | disclosed |
| CN-109476721-B | CD 8-specific capture agents, compositions and methods of use and preparation | 英蒂分子公司 | 2022-06-28 | — | — | CN | disclosed |
| EP-3198284-B1 | PALETTE-BASED SYSTEMS FOR ANALYTE CHARACTERIZATION | TRACE ABILITY INC (US) | 2022-03-30 | — | — | EP | disclosed |
| US-20220073552-A1 | REAGENT AND PROCESS FOR THE SITE-SPECIFIC DEOXYFLUORINATION OF PEPTIDES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2022-03-10 | — | — | US | disclosed |
| US-20220062222-A1 | CROMOLYN ESTERS AND USES THEREOF | THE GENERAL HOSPITAL CORPORATION | 2022-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612391-B2 | Cromolyn derivatives and uses thereof | HTT, PRNP, PSEN1 | KDM4E 4158/4885MAPT 20/4885CYP1A2 3981/4885 |
| US-20220062222-A1 | CROMOLYN ESTERS AND USES THEREOF | PRNP, HTT, PSEN1 | KDM4E 4274/4885MAPT 15/4885CYP1A2 3935/4885 |
| US-12383528-B2 | Cromolyn esters and uses thereof | PRNP, HTT, PSEN1 | KDM4E 4274/4885MAPT 15/4885CYP1A2 3935/4885 |
| US-20250025581-A1 | Medical Imaging of Glycogen Synthase Kinase-3 with a PET Probe | GYS2, GYS1, PKN3 | KDM4E 1926/4885MAPT 2564/4885CYP1A2 2072/4885 |
| US-20260014284-A1 | PROCESS FOR PREPARATION OF RADIOLABELED STYRYLPYRIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF | NEFM, APP, PSEN2 | KDM4E 2398/4885MAPT 13/4885CYP1A2 746/4885 |
| US-20240327361-A1 | RADIOLABELED COMPOSITIONS AND METHODS OF USE THEREOF | HDAC1, HDAC3, HDAC5 | KDM4E 114/4885MAPT 702/4885CYP1A2 2630/4885 |
| US-12090157-B2 | Non-invasive pet imaging of CDK4/6 activation in cancer | CDK4, CDK6, CDKL4 | KDM4E 746/4885MAPT 4079/4885CYP1A2 4104/4885 |
| US-12583881-B2 | Device and cassette for performing a plurality of synthesis processes of preparing a radiopharmaceutical in series | TMEM14C, FLT1, SLC6A12 | KDM4E 2188/4885MAPT 3148/4885CYP1A2 1915/4885 |
| US-20220073552-A1 | REAGENT AND PROCESS FOR THE SITE-SPECIFIC DEOXYFLUORINATION OF PEPTIDES | DNPEP, TYRO3, ABL1 | KDM4E 2281/4885MAPT 3342/4885CYP1A2 2822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.